Cold agglutinin disease following allogeneic bone marrow transplantation. 1994

T Tamura, and H Kanamori, and E Yamazaki, and M Ohtsuka, and K Hataoka, and K Maeda, and R Okamoto, and J Tanabe, and H Fujita, and Y Hashimoto
First Department of Internal Medicine, Yokohama City University School of Medicine, Japan.

We describe a case of cold agglutinin disease (CAD) following allogeneic bone marrow transplantation. This 36-year-old male developed CAD 3 weeks after allogeneic bone marrow transplantation for chronic myelogenous leukemia. Cyclosporin A and methotrexate had been administered to prevent graft-versus-host disease. Other agents administered included cytomegalovirus hyperimmune globulin and recombinant human G-CSF. Pericarditis preceded the development of CAD. The characterization of cold agglutinin (CA) was monoclonal IgM-kappa with anti-Pr antigen specificity, probably derived from the engrafted donor lymphocytes. The administration of prednisolone led to transient improvement. The CA titer decreased without further treatment 12 weeks after transplant.

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000744 Anemia, Hemolytic, Autoimmune Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS. Anemia, Hemolytic, Idiopathic Acquired,Autoimmune Haemolytic Anaemia,Autoimmune Hemolytic Anemia,Cold Agglutinin Disease,Hemolytic Anemia, Autoimmune,Acquired Autoimmune Hemolytic Anemia,Anemia, Hemolytic, Cold Antibody,Cold Antibody Disease,Cold Antibody Hemolytic Anemia,Idiopathic Autoimmune Hemolytic Anemia,Agglutinin Disease, Cold,Anaemia, Autoimmune Haemolytic,Anemia, Autoimmune Hemolytic,Autoimmune Haemolytic Anaemias,Autoimmune Hemolytic Anemias,Cold Agglutinin Diseases,Cold Antibody Diseases,Haemolytic Anaemia, Autoimmune
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting

Related Publications

T Tamura, and H Kanamori, and E Yamazaki, and M Ohtsuka, and K Hataoka, and K Maeda, and R Okamoto, and J Tanabe, and H Fujita, and Y Hashimoto
August 2005, Bone marrow transplantation,
T Tamura, and H Kanamori, and E Yamazaki, and M Ohtsuka, and K Hataoka, and K Maeda, and R Okamoto, and J Tanabe, and H Fujita, and Y Hashimoto
October 1994, Bone marrow transplantation,
T Tamura, and H Kanamori, and E Yamazaki, and M Ohtsuka, and K Hataoka, and K Maeda, and R Okamoto, and J Tanabe, and H Fujita, and Y Hashimoto
February 1989, Irish journal of medical science,
T Tamura, and H Kanamori, and E Yamazaki, and M Ohtsuka, and K Hataoka, and K Maeda, and R Okamoto, and J Tanabe, and H Fujita, and Y Hashimoto
October 1992, Current opinion in immunology,
T Tamura, and H Kanamori, and E Yamazaki, and M Ohtsuka, and K Hataoka, and K Maeda, and R Okamoto, and J Tanabe, and H Fujita, and Y Hashimoto
January 2001, Hematology (Amsterdam, Netherlands),
T Tamura, and H Kanamori, and E Yamazaki, and M Ohtsuka, and K Hataoka, and K Maeda, and R Okamoto, and J Tanabe, and H Fujita, and Y Hashimoto
December 1984, Japanese journal of clinical oncology,
T Tamura, and H Kanamori, and E Yamazaki, and M Ohtsuka, and K Hataoka, and K Maeda, and R Okamoto, and J Tanabe, and H Fujita, and Y Hashimoto
March 1978, Transplantation proceedings,
T Tamura, and H Kanamori, and E Yamazaki, and M Ohtsuka, and K Hataoka, and K Maeda, and R Okamoto, and J Tanabe, and H Fujita, and Y Hashimoto
October 1991, American journal of hematology,
T Tamura, and H Kanamori, and E Yamazaki, and M Ohtsuka, and K Hataoka, and K Maeda, and R Okamoto, and J Tanabe, and H Fujita, and Y Hashimoto
January 2000, Haematologica,
T Tamura, and H Kanamori, and E Yamazaki, and M Ohtsuka, and K Hataoka, and K Maeda, and R Okamoto, and J Tanabe, and H Fujita, and Y Hashimoto
July 1996, Bone marrow transplantation,
Copied contents to your clipboard!